| | | | | | | |
 | MODERNA, INC. | -0.60% | -2.00% | 6.94% | 29.25% | 744.72% | 74 239 |
 | LONZA GROUP AG | -0.23% | 8.46% | 16.93% | -13.63% | 34.30% | 42 748 |
| IQVIA HOLDINGS INC. | 0.28% | 2.80% | 11.85% | -1.22% | 45.81% | 42 445 |
| ALNYLAM PHARMACEUTICALS, INC. | -0.71% | -1.20% | -3.24% | 80.81% | 96.49% | 28 492 |
| SEAGEN INC. | 0.52% | 5.83% | 9.27% | 14.24% | 27.15% | 25 936 |
 | CELLTRION, INC. | 0.49% | 0.79% | 2.99% | 10.20% | 1.91% | 19 184 |
| ICON PUBLIC LIMITED COMPANY | -1.03% | 2.25% | 17.72% | -10.90% | 33.09% | 18 864 |
 | HANGZHOU TIGERMED CONSULTING CO., LTD. | -1.24% | 1.89% | 17.73% | 13.20% | 68.41% | 15 246 |
| PHARMARON BEIJING CO., LTD. | -0.36% | 2.25% | 21.62% | 3.39% | 111.69% | 13 856 |
| BIO-TECHNE CORPORATION | 0.61% | -0.20% | -2.50% | -8.65% | 49.10% | 12 608 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | -0.03% | 4.61% | 12.08% | -21.79% | 58.00% | 12 429 |
| UNITED THERAPEUTICS CORPORATION | -0.51% | 1.62% | -5.46% | 34.70% | 191.94% | 12 043 |
| QIAGEN N.V. | -0.53% | 0.98% | -0.45% | 4.89% | 43.27% | 11 365 |
 | GENSCRIPT BIOTECH CORPORATION | 1.38% | 4.51% | 18.11% | 17.64% | 59.86% | 7 822 |
| MEDPACE HOLDINGS, INC. | 0.27% | -1.70% | 7.50% | 38.18% | 160.44% | 7 064 |
| | | | | | | |
| | Durchschnitt | -0.11% | 2.06% | 8.74% | 12.69% | 115.08% | |
| | Gewichteter Durchschnitt nach Marktkapitalisierung | -0.22% | 1.96% | 8.98% | 14.37% | 206.62% | |
Google
Twitter
Facebook
Apple
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Bericht
